GSK PLC closed 20.35% short of its 52-week high of £18.24, which the company achieved on May 16th.

Britain's blue-chip FTSE 100 kicked off the week higher on Monday, boosted by heavyweight healthcare and defence stocks, on ...

Innoviva's shift to specialty therapeutics is backed by strong financials and a robust pipeline. Read why INVA stock presents ...

GSK Plc is a long-term underperformer among Europe’s Big Pharma stocks. And with key drug patents set to expire and vaccine ...

NEW YORK CITY, NY / ACCESS Newswire / February 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law ...

The Government of Canada has secured an initial supply of 500,000 doses of GSK's bird flu vaccine to protect individuals most ...

GSK PLC closed 20.87% below its 52-week high of £18.24, which the company reached on May 16th.

A Centers for Disease Control and Prevention vaccine advisory committee meeting scheduled for next week — the first since ...

Martin has since learned that shingles is caused by the reactivation of the varicella zoster virus, the same virus that ...

GSK plc has completed its previously announced acquisition of IDRx Inc., a Boston-based, clinical-stage biopharmaceutical ...

The company's consolidated net profit jumped multifold to Rs 230 crore as compared to Rs 46 crore a year ago in the December ...